Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Nugen Medical Devices Inc
NuGen Medical Devices begins feasibility study in the Netherlands for InsuJet and Ozempic
Business
Apr 27 2023
5 min read

NuGen Medical Devices begins feasibility study in the Netherlands for InsuJet and Ozempic

NuGen Medical Devices begins feasibility study in the Netherlands for InsuJet and Ozempic

(NewsDirect)

NuGen Medical Devices executive chairman Tony Di Benedetto joined Steve Darling from Proactive to provide details about the company that is developing the next generation of needle-free technologies for both humans and animals.

Di Benedetto shares with Proactive more about the technology behind products InsuJet and PetJet and also about an assessment and feasibility study in the Netherlands of InsuJet for Semaglutide or its more widely known name Ozempic.

Contact Details

Proactive Investors

+1 604-688-8158

na-editorial@proactiveinvestors.com

Copyright (c) 2023 TheNewswire - All rights reserved.